SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

SOKOLOW LEONARD J

(Last)

(First)

(Middle)

C/O SQL TECHNOLOGIES CORP.

11030 JONES BRIDGE ROAD, SUITE 206

(Street)

JOHNS CREEK

30022

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
SQL Technologies Corp. [ SKYX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/14/2022

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, no par value	02/14/2022		J⁽⁷⁾		86,032⁽⁷⁾	A	⁽⁷⁾	317,656	I	By Bridge Line Ventures⁽²⁾
Common Stock, no par value								309,667	D
Common Stock, no par value								3,600	I	By Newbridge Securities Corporation⁽¹⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (right to buy)	$0.6							11/15/2015	11/15/2025	Common Stock, no par value	150,000		150,000	D
Stock Option (right to buy)	$3							06/30/2017	04/19/2027	Common Stock, no par value	150,000		150,000	D
Stock Option (right to buy)	$4							12/31/2017	04/19/2027	Common Stock, no par value	150,000		150,000	D
Stock Option (right to buy)	$3							01/01/2018	01/01/2023	Common Stock, no par value	100,000		100,000	D
Stock Option (right to buy)	$3							01/01/2019	01/01/2024	Common Stock, no par value	100,000		100,000	D
Stock Option (right to buy)	$12							01/01/2020	01/01/2025	Common Stock, no par value	100,000		100,000	D
Stock Option (right to buy)	$12							12/31/2020	12/31/2025	Common Stock, no par value	100,000		100,000	D
Stock Option (right to buy)	$12							12/31/2021	12/31/2026	Common Stock, no par value	100,000		100,000	D
Warrant (right to buy)	$12							⁽³⁾	12/31/2023	Common Stock, no par value	4,469		4,469	D
Warrant (right to buy)	$12							⁽³⁾	10/26/2024	Common Stock, no par value	1,088		1,088	D
Warrant (right to buy)	$12							⁽³⁾	11/29/2024	Common Stock, no par value	3,375		3,375	D
Warrant (right to buy)	$12							⁽³⁾	12/22/2024	Common Stock, no par value	19,827		19,827	D
Warrant (right to buy)	$12							⁽³⁾	12/31/2023	Common Stock, no par value	5,674		5,674	I	By Newbridge Securities Corporation⁽¹⁾
Warrant (right to buy)	$12							⁽³⁾	10/26/2024	Common Stock, no par value	725		725	I	By Newbridge Securities Corporation⁽¹⁾
Warrant (right to buy)	$12							⁽³⁾	11/29/2024	Common Stock, no par value	2,250		2,250	I	By Newbridge Securities Corporation⁽¹⁾
Warrant (right to buy)	$12							⁽³⁾	12/22/2024	Common Stock, no par value	13,216		13,216	I	By Newbridge Securities Corporation⁽¹⁾
Warrant (right to buy)	$9.8⁽⁴⁾							⁽⁴⁾	06/30/2024	Common Stock, no par value	214,957		214,957	I	By Bridge Line Ventures⁽²⁾
Warrant (right to buy)	$9.8⁽⁴⁾							⁽⁴⁾	08/31/2024	Common Stock, no par value	16,667		16,667	I	By Bridge Line Ventures⁽²⁾
6.0% Subordinated Convertible Promissory Note⁽⁵⁾	$15							⁽⁵⁾	09/22/2023	Common Stock, no par value	$250,000⁽⁶⁾		$250,000⁽⁶⁾	D

Explanation of Responses:

1. These securities are owned by Newbridge Securities Corporation. The reporting person is the Chief Executive Officer and President of Newbridge Financial, Inc. and Chairman of Newbridge Securities Corporation, its broker dealer subsidiary.

2. These securities are owned by Bridge Line Ventures, LLC Series ST-1 ("Bridge Line Ventures"). The reporting person is the Chief Executive Officer and President of Bridge Line Advisors, LLC, the manager of Bridge Line Ventures.

3. Exercisable at any time on or prior to the expiration date at the holder's discretion at the initial exercise price of $12.00, subject to adjustment provisions (including certain anti-dilution provisions).

4. Exercisable at any time on or prior to the expiration date at the holder's discretion at the adjusted exercise price of $9.80, subject to adjustment provisions (including certain anti-dilution provisions). The initial exercise price of $12.00 per share was automatically adjusted pursuant to applicable anti-dilution provisions in connection with the completion of the issuer's initial public offering.

5. The principal amount, plus any accrued and unpaid interest, is convertible at any time on or prior to the maturity date at the holder's discretion at the conversion price of $15.00. This note was inadvertently omitted from the reporting person's Form 3.

6. Represents the principal amount of the convertible note and excludes interest that may accrue. Interest on the note is payable annually, in cash or common stock, at the holder's discretion.

7. The shares were issued pursuant to anti-dilution provisions set forth in the terms of the stock purchase agreements entered into between the issuer and Bridge Line Ventures between February 2021 and August 2021.

Remarks:

Power of Attorney is attached hereto as Exhibit 24.

	/s/ Leonard J. Sokolow	02/14/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.